ArticleOPEN ACCESS

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

American Journal of Hematology
DOI: 10.1002/ajh.25332
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Bahashwan, S., Moluçon-Chabrot, C., Hermet, E., Ravinet, A., Douge, A., Veronese, L., … Guièze, R. (2019, January 1). Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia. American Journal of Hematology. Wiley-Liss Inc. https://doi.org/10.1002/ajh.25332

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free